Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Metabolic effects of a growth hormone-releasing factor in patients with HIV.
- J. Falutz, S. Allas, S. Grinspoon
- MedicineThe New England journal of medicine
- 6 December 2007
TLDR
Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader–Willi syndrome
- R. Kuppens, G. Diene, A. Hokken-Koelega
- MedicineEndocrine
- 20 May 2015
TLDR
Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation
- J. Falutz, S. Allas, S. Grinspoon
- MedicineAIDS
- 12 September 2008
TLDR
A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation
- J. Falutz, S. Allas, S. Grinspoon
- MedicineAIDS
- 12 August 2005
TLDR
Safety, tolerability, pharmacokinetics and pharmacodynamics of AZP‐531, a first‐in‐class analogue of unacylated ghrelin, in healthy and overweight/obese subjects and subjects with type 2 diabetes
- S. Allas, T. Delale, A. J. van der Lely
- Medicine, BiologyDiabetes, obesity & metabolism
- 1 September 2016
To explore the safety, pharmacokinetics and pharmacodynamics in humans of the unacylated ghrelin analogue AZP‐531, designed to improve glycaemic control and reduce weight.
Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines
- W. Chien, Céline Le Beux, G. Salles
- Biology, MedicineScientific reports
- 28 January 2015
TLDR
In vitro and in vivo stability and pharmacokinetic profile of unacylated ghrelin (UAG) analogues.
- M. Julien, R. Kay, T. Abribat
- Biology, ChemistryEuropean journal of pharmaceutical sciences…
- 20 November 2012
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
TLDR
Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase
TLDR
Unacylated ghrelin analog prevents myocardial reperfusion injury independently of permeability transition pore
- Rania Harisseh, B. Pillot, M. Ovize
- BiologyBasic Research in Cardiology
- 2016
TLDR
...
1
2
3
4
...